Herbert Virgin Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Herbert Virgin is EVP, Research & CSO of Vir Biotechnology, Inc.. Currently has a direct ownership of 262,500 shares of VIR, which is worth approximately $1.76 Million. The most recent transaction as insider was on Aug 09, 2022, when has been sold 78,093 shares (Common Stock) at a price of $5.96 per share, resulting in proceeds of $465,434. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K
0% 3M change
0% 12M change
Total Value Held $1.76 Million

Herbert Virgin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2022
BUY
Exercise of conversion of derivative security
$465,434 $5.96 p/Share
78,093 Added 22.93%
262,500 Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
$13,770 $1.53 p/Share
9,000 Added 4.65%
184,407 Common Stock
Feb 22 2022
SELL
Open market or private sale
$41,250 $30.0 p/Share
1,375 Reduced 0.78%
175,407 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
-
70,000 Added 28.52%
175,407 Common Stock
Feb 22 2022
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 0.77%
176,782 Common Stock
Feb 17 2022
SELL
Open market or private sale
$73,215 $31.93 p/Share
2,293 Reduced 2.13%
105,407 Common Stock
Feb 08 2022
SELL
Open market or private sale
$46,667 $33.94 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Feb 08 2022
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Jan 25 2022
SELL
Open market or private sale
$44,632 $32.46 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Jan 25 2022
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Jan 11 2022
SELL
Open market or private sale
$48,262 $35.1 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Dec 28 2021
SELL
Open market or private sale
$54,931 $39.95 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Dec 28 2021
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Dec 15 2021
SELL
Open market or private sale
$137,500 $50.0 p/Share
2,750 Reduced 2.49%
107,700 Common Stock
Dec 15 2021
BUY
Exercise of conversion of derivative security
$4,207 $1.53 p/Share
2,750 Added 2.43%
110,450 Common Stock
Dec 14 2021
SELL
Open market or private sale
$63,085 $45.88 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Dec 14 2021
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Nov 30 2021
SELL
Open market or private sale
$722,975 $47.8 p/Share
15,125 Reduced 12.31%
107,700 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
$23,141 $1.53 p/Share
15,125 Added 10.96%
122,825 Common Stock
Nov 16 2021
SELL
Open market or private sale
$44,921 $32.67 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Nov 02 2021
SELL
Open market or private sale
$50,792 $36.94 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
Nov 02 2021
BUY
Exercise of conversion of derivative security
$2,104 $1.53 p/Share
1,375 Added 1.24%
109,075 Common Stock
Oct 19 2021
SELL
Open market or private sale
$53,446 $38.87 p/Share
1,375 Reduced 1.26%
107,700 Common Stock
HV

Herbert Virgin

EVP, Research & CSO
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if
Any

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR